WallStreetZenWallStreetZen

NASDAQ: NRIX
Nurix Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

NRIX past revenue growth

How has NRIX's revenue growth performed historically?
Company
94.02%
Industry
145.73%
Market
17.2%
NRIX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NRIX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NRIX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NRIX earnings and revenue history

Current Revenue
$80.9M
Current Earnings
-$144.7M
Current Profit Margin
-178.9%

NRIX Return on Equity

Current Company
-67.1%
Current Industry
-18.4%
Current Market
28.2%
NRIX's Return on Equity (-67.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when NRIX announces earnings.

NRIX Return on Assets

Current Company
-43.6%
Current Industry
0.7%
NRIX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NRIX Return on Capital Employed

Current Company
-64.27%
Current Industry
13.8%
NRIX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NRIX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NRIX$80.89M-$130.28M-$144.73M+145.04%N/A
AVTE$0.00-$75.37M-$75.52MN/AN/A
SVRA$0.00-$50.09M-$54.70M-100.00%N/A
DNTH$2.83M-$43.20M-$43.56M-55.96%N/A
HLVX$0.00-$119.02M-$123.57MN/AN/A
View Top Biotech Stocks

NRIX earnings dates

Next earnings date
May 20, 2024

Nurix Therapeutics Earnings & Revenue FAQ

What were NRIX's earnings last quarter?

On Invalid Date, Nurix Therapeutics (NASDAQ: NRIX) reported Q1 2024 earnings per share (EPS) of -$0.76, up 1.33% year over year. Total Nurix Therapeutics earnings for the quarter were -$41.52 million. In the same quarter last year, Nurix Therapeutics's earnings per share (EPS) was -$0.75.

If you're new to stock investing, here's how to buy Nurix Therapeutics stock.

What was NRIX's earnings growth in the past year?

As of Q2 2024, Nurix Therapeutics's earnings has grown year over year. Nurix Therapeutics's earnings in the past year totalled -$144.73 million.

What is NRIX's earnings date?

Nurix Therapeutics's earnings date is Invalid Date. Add NRIX to your watchlist to be reminded of NRIX's next earnings announcement.

What was NRIX's revenue last quarter?

On Invalid Date, Nurix Therapeutics (NASDAQ: NRIX) reported Q1 2024 revenue of $16.59 million up 30.74% year over year. In the same quarter last year, Nurix Therapeutics's revenue was $12.69 million.

What was NRIX's revenue growth in the past year?

As of Q2 2024, Nurix Therapeutics's revenue has grown 94.02% year over year. This is 51.72 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Nurix Therapeutics's revenue in the past year totalled $80.89 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.